ArticleInfection and immunity2017
Th17-Mediated Cross Protection against Pneumococcal Carriage by Vaccination with a Variable Antigen.
Open access · bronzeAbstract read
In one paragraph
Article in Infection and immunity, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 34 citations in OpenAlex.
- The Case for Pneumococcal Surface Protein A (PspA): A Comprehensive Review of a Leading Candidate in Pneumococcal Vaccine Research.Vaccines · 2026Review
- Tracking spatio-temporal dynamics of early immune responses to an intranasal OMV-based pneumococcal vaccine candidate in mice.NPJ vaccines · 2026Article
- Intranasal delivery ofHuman vaccines & immunotherapeutics · 2024Article
- A broad-spectrum pneumococcal vaccine induces mucosal immunity and protects against lethalEmerging microbes & infections · 2023Article
- Article
- Heterologous Display ofMembranes · 2023Article
- Overexpression of the Bam Complex Improves the Production ofInternational journal of molecular sciences · 2022Article
- An Intranasal OMV-Based Vaccine Induces High Mucosal and Systemic Protecting Immunity Against a SARS-CoV-2 Infection.Frontiers in immunology · 2021Article
- Exploring metal availability in the natural niche ofVirulence · 2020Article
- Immunologic dysfunction contributes to the otitis prone condition.The Journal of infection · 2020Review
- Article
- Development of Next GenerationVaccines · 2020Review
- Combining Protein Ligation Systems to Expand the Functionality of Semi-Synthetic Outer Membrane Vesicle Nanoparticles.Frontiers in microbiology · 2020Article
- Respiratory Barrier as a Safeguard and Regulator of Defense Against Influenza A Virus andFrontiers in immunology · 2020Review
- Vaccines to Prevent Infectious Diseases in the Older Population: Immunological Challenges and Future Perspectives.Frontiers in immunology · 2020Review
- Outer Membrane Vesicles ofFrontiers in microbiology · 2020Article
- Double-Edged Role of Interleukin 17A in Streptococcus pneumoniae Pathogenesis During Influenza Virus Coinfection.The Journal of infectious diseases · 2019Article
- Prediction and Validation of Immunogenic Domains of Pneumococcal Proteins Recognized by Human CD4Infection and immunity · 2019Article
- Review
- Display of Recombinant Proteins on Bacterial Outer Membrane Vesicles by Using Protein Ligation.Applied and environmental microbiology · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors at 5 institutions in 3 countries.
Kirsten KuipersLaboratory of Pediatric Infectious Diseases, Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands.
Wouter S P JongAbera Bioscience AB, Stockholm, Sweden.
Christa E van der Gaast-de JonghLaboratory of Pediatric Infectious Diseases, Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands.
Diane HoubenSection Molecular Microbiology, Department of Molecular Cell Biology, Faculty of Earth and Life Sciences, VU University, Amsterdam, The Netherlands.
Fred van OpzeelandLaboratory of Pediatric Infectious Diseases, Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands.
Elles SimonettiLaboratory of Pediatric Infectious Diseases, Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands.
Saskia van SelmLaboratory of Pediatric Infectious Diseases, Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands.
Ronald de GrootLaboratory of Pediatric Infectious Diseases, Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands.
Marije I KoendersExperimental Rheumatology, Radboud University Medical Center, Nijmegen, The Netherlands.
Taj AzarianCenter for Communicable Diseases Dynamics, Department of Epidemiology, Harvard University, Boston, Massachusetts, USA.ORCID http://orcid.org/0000-0002-8611-5241
Elder PupoInstitute for Translational Vaccinology (Intravacc), Bilthoven, The Netherlands.
Peter van der LeyInstitute for Translational Vaccinology (Intravacc), Bilthoven, The Netherlands.
Jeroen D LangereisLaboratory of Pediatric Infectious Diseases, Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands.
Aldert ZomerDepartment of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands.
Joen LuirinkSection Molecular Microbiology, Department of Molecular Cell Biology, Faculty of Earth and Life Sciences, VU University, Amsterdam, The Netherlands.
Marien I de JongeLaboratory of Pediatric Infectious Diseases, Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands marien.dejonge@radboudumc.nl.
Radboud University Nijmegen · NLAbera Bioscience (Sweden) · SEIntravacc (Netherlands) · NLCenter for Disease Dynamics, Economics & Policy · USUtrecht University · NL
Funding
VACCINATION AND THE EVOLUTIONARY DYNAMICS OF PNEUMOCOCCIR01AI048935 · NIAID · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI LIPSITCH, MARC · 2001 to 2016
$8.8MNIAID NIH HHS R01 AI048935
Abstract
Serotype-specific protection against
Indexed as
Cross ProtectionAdministration, IntranasalAnimalsAntigens, BacterialBacterial Outer Membrane ProteinsBacterial ProteinsComputer SimulationEpitopesGenes, MHC Class IIHeat-Shock ProteinsInterleukin-17LipopolysaccharidesMicePneumococcal InfectionsPneumococcal VaccinesSalmonella typhimuriumAntigens, BacterialBacterial Outer Membrane ProteinsBacterial ProteinsEpitopesHeat-Shock ProteinsInterleukin-17Lipopolysaccharidesphage shock protein, BacteriaPneumococcal Vaccinesantigen surface displayautotransporter Hbpbroad protectioncolonizationintranasal vaccinationprotein antigensPspASalmonella outer membrane vesicle (OMV)Streptococcus pneumoniaeTh17
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.